Compounding the Off-Label Promotion Debate: How FDA Could Regulate the Promotion of Unapproved Drugs

Update Magazine | September/October 2017

Compounding the Off-Label Promotion Debate: How FDA Could Regulate the Promotion of Unapproved Drugs2017-11-16T13:49:29-05:00

Intellectual Property for the Food and Drug Law Professional: Issues that Arise in the Product Development Process

Update Magazine | September/October 2017

Intellectual Property for the Food and Drug Law Professional: Issues that Arise in the Product Development Process2017-11-16T13:49:39-05:00

The “New” NDC: Are You Aware of FDA’s Rollout of the New Unique Medical Device Identifier (UDI) and Its Potential Future Impact on Payer Claims Forms?

Update Magazine | September/October 2017

The “New” NDC: Are You Aware of FDA’s Rollout of the New Unique Medical Device Identifier (UDI) and Its Potential Future Impact on Payer Claims Forms?2017-11-16T13:49:48-05:00

Regulatory Update on Acrylamide—State, Federal, and International Oversight

Update Magazine | September/October 2017

Regulatory Update on Acrylamide—State, Federal, and International Oversight2017-11-16T13:53:34-05:00
Image containing different sponsors that contribute to FDLI

1015 15th St NW, Suite 300
Washington, DC 20005

202-371-1420

Virtual Learning

Programs

Resources

Get Involved

Career

About

© 2025 FDLI

Terms of Use

Privacy Policy

Go to Top